NRGene Technologies Ltd (TLV:NRGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 164.10
0.00 (0.00%)
Aug 20, 2026, 1:11 PM IDT
NRGene Technologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.14 | 1.29 | 6.45 | 12.28 | 8.85 |
Short-Term Investments | 1.16 | 0.08 | - | - | 14.02 |
Cash & Short-Term Investments | 5.3 | 1.37 | 6.45 | 12.28 | 22.87 |
Cash Growth | 285.94% | -78.71% | -47.49% | -46.29% | 1443.32% |
Accounts Receivable | 0.04 | 0.12 | 0.12 | 0.54 | 0.14 |
Other Receivables | 0.29 | 0.24 | 0.12 | 0.58 | 0.32 |
Receivables | 0.32 | 0.36 | 0.24 | 1.12 | 0.46 |
Inventory | 0.06 | 0.12 | - | - | - |
Prepaid Expenses | 0.09 | 0.14 | 0.38 | 0.66 | 0.53 |
Restricted Cash | 0.07 | 0.14 | 0.13 | 0.22 | 0.22 |
Other Current Assets | 0.39 | - | - | - | - |
Total Current Assets | 6.23 | 2.13 | 7.2 | 14.29 | 24.08 |
Property, Plant & Equipment | 0.36 | 0.38 | 1.33 | 1.27 | 1.44 |
Long-Term Investments | - | - | - | - | 0.19 |
Other Intangible Assets | 2.95 | 3.4 | 2.26 | 1.75 | 0.66 |
Long-Term Accounts Receivable | - | 0.09 | - | - | - |
Total Assets | 9.54 | 6 | 10.79 | 17.3 | 26.37 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.1 | 0.19 | 0.25 | 0.38 | 0.4 |
Accrued Expenses | 1.37 | 0.93 | 1.02 | 1.17 | 1.7 |
Short-Term Debt | - | - | 0.91 | 0.82 | 1.31 |
Current Portion of Long-Term Debt | - | - | - | - | 0.39 |
Current Portion of Leases | 0.13 | 0.22 | 0.26 | 0.32 | 0.26 |
Current Unearned Revenue | 2.4 | 0.57 | 0.48 | 1.2 | 2.64 |
Other Current Liabilities | 1.07 | - | - | - | - |
Total Current Liabilities | 5.06 | 1.91 | 2.9 | 3.9 | 6.7 |
Long-Term Debt | - | - | - | - | 0.59 |
Long-Term Leases | 0.05 | 0.07 | 0.54 | 0.47 | 0.8 |
Long-Term Unearned Revenue | 0.01 | 0.02 | 0.13 | 0.68 | 0.6 |
Total Liabilities | 5.13 | 2 | 3.57 | 5.05 | 8.68 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Additional Paid-In Capital | 51.71 | 50.99 | 49.29 | 48.86 | 47.96 |
Retained Earnings | -54.86 | -53.35 | -49.99 | -44.75 | -38.54 |
Comprehensive Income & Other | 7.42 | 6.29 | 7.88 | 8.12 | 8.23 |
Total Common Equity | 4.31 | 3.96 | 7.21 | 12.26 | 17.68 |
Minority Interest | 0.11 | 0.04 | - | - | - |
Shareholders' Equity | 4.42 | 4.01 | 7.21 | 12.26 | 17.68 |
Total Liabilities & Equity | 9.54 | 6 | 10.79 | 17.3 | 26.37 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.18 | 0.29 | 1.7 | 1.61 | 3.34 |
Net Cash (Debt) | 5.12 | 1.09 | 4.75 | 10.67 | 19.53 |
Net Cash Growth | 371.70% | -77.15% | -55.50% | -45.36% | - |
Net Cash Per Share | 0.39 | 0.09 | 0.38 | 0.86 | 1.62 |
Filing Date Shares Outstanding | 13.27 | 13.01 | 12.6 | 12.52 | 12.38 |
Total Common Shares Outstanding | 13.27 | 13.01 | 12.6 | 12.52 | 12.38 |
Working Capital | 1.16 | 0.22 | 4.3 | 10.39 | 17.38 |
Book Value Per Share | 0.32 | 0.30 | 0.57 | 0.98 | 1.43 |
Tangible Book Value | 1.36 | 0.56 | 4.96 | 10.51 | 17.02 |
Tangible Book Value Per Share | 0.10 | 0.04 | 0.39 | 0.84 | 1.37 |
Machinery | 0.32 | 0.38 | 0.94 | 0.86 | 0.66 |
Leasehold Improvements | 0.22 | 0.19 | 0.15 | 0.08 | 0.08 |